Molecular Testing in Patients With Resectable or Metastatic NSCLC | For the Lung Cancer Nursing Team

Автор: Lung Cancer Connect, sponsored by AZ Oncology

Загружено: 2022-06-21

Просмотров: 167

Описание: Nurse navigators and nurse practitioners share expert perspectives on explaining the importance of molecular testing to patients with resectable or metastatic non-small cell lung cancer (NSCLC).

Featuring:
-Moderator: Benjamin Levy, MD (Associate Professor, Johns Hopkins School of Medicine; Clinical Director of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital)
-Kim Rohan, ANP-BC, AOCN (Edward Hospital & Health Services)
-Claudia Miller, BSN, RN, OCN, ONN-CG (Medical University of South Carolina)
-Lauren Welch, MSN, NP-C, AOCNP (Tennessee Oncology/Sarah Cannon Research Institute)
-Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC (University of Kentucky Markey Cancer Center)
-Rasheda Persinger, MSN, NP-C (Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital)

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...

Molecular Testing in Patients With Resectable or Metastatic NSCLC | For the Lung Cancer Nursing Team

Доступные форматы для скачивания:

Скачать видео

Информация по загрузке:

Скачать аудио

Похожие видео

Addressing Unmet Needs for Patients With Resectable NSCLC and the Benefits of an MDT Approach

Addressing Unmet Needs for Patients With Resectable NSCLC and the Benefits of an MDT Approach

PERIOPERATIVE TREATMENT APPROACH IN RESECTABLE NSCLC Part 1: A surgeon’s perspective

PERIOPERATIVE TREATMENT APPROACH IN RESECTABLE NSCLC Part 1: A surgeon’s perspective

Considerations for Optimizing CRT in NSCLC: Patient Cases

Considerations for Optimizing CRT in NSCLC: Patient Cases

How to start a community-based lung cancer screening program

How to start a community-based lung cancer screening program

Beyond the Blade: 5 reasons thoracic surgeons may use perioperative IO-based regimens before surgery

Beyond the Blade: 5 reasons thoracic surgeons may use perioperative IO-based regimens before surgery

Firefighters, Veterans, and Lung Cancer

Firefighters, Veterans, and Lung Cancer

Diagnosis and Staging of Unresectable Stage III NSCLC

Diagnosis and Staging of Unresectable Stage III NSCLC

Managing CRT-induced Adverse Events in Unresectable Stage III NSCLC

Managing CRT-induced Adverse Events in Unresectable Stage III NSCLC

Optimizing CRT in Unresectable Stage III NSCLC

Optimizing CRT in Unresectable Stage III NSCLC

Importance of an evidence-based lung cancer screening program in the community setting

Importance of an evidence-based lung cancer screening program in the community setting

PERIOPERATIVE TREATMENT APPROACH IN RESECTABLE NSCLC Part 2: Ensuring appropriate treatment

PERIOPERATIVE TREATMENT APPROACH IN RESECTABLE NSCLC Part 2: Ensuring appropriate treatment

Beyond the Blade: Ways thoracic surgeons can talk to patients about perioperative IO-based regimens

Beyond the Blade: Ways thoracic surgeons can talk to patients about perioperative IO-based regimens

Causes of Lung Cancer

Causes of Lung Cancer

Lung Cancer Screening and Prevention

Lung Cancer Screening and Prevention

Lung Cancer Treatments

Lung Cancer Treatments

What Lungs Do

What You Should Know about the Two Main Types of Lung Cancer

What You Should Know about the Two Main Types of Lung Cancer

What Your Lungs Do and Keeping Them Healthy

What Your Lungs Do and Keeping Them Healthy

Rethinking a Lung Cancer Diagnosis

Rethinking a Lung Cancer Diagnosis

Targeted Therapy

Targeted Therapy